Children’s Wisconsin delivers first FDA-approved gene therapy for genetic hearing loss outside clinical trial
Children’s Wisconsin says it is the first U.S. center to deliver FDA-approved Otarmeni gene therapy for OTOF-related genetic hearing loss outside a clinical trial.
By
